JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Irving L. Kron
Victor E. Laubach
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, Z.
Right arrow Articles by Laubach, V. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Yang, Z.
Right arrow Articles by Laubach, V. E.
Related Collections
Right arrow Lung - transplantation

J Thorac Cardiovasc Surg 2009;137:695-702
© 2009 The American Association for Thoracic Surgery


Cardiothoracic Transplantation

CD4+ T lymphocytes mediate acute pulmonary ischemia–reperfusion injury

Zequan Yang, MD, PhDa, Ashish K. Sharma, MBBSa, Joel Linden, PhDb, Irving L. Kron, MDa, Victor E. Laubach, PhDa,*

a Department of Surgery, University of Virginia Health System, Charlottesville, Va
b Department of Medicine, University of Virginia Health System, Charlottesville, Va

Received for publication April 17, 2008; revisions received September 18, 2008; accepted for publication October 13, 2008.

* Address for reprints: Victor E. Laubach, PhD, University of Virginia Health System, Department of Surgery, PO Box 801359, Charlottesville, VA 22908. (Email: laubach{at}virginia.edu).

Objective: Postischemic reperfusion of the lung triggers proinflammatory responses that stimulate injurious neutrophil chemotaxis. We hypothesized that T lymphocytes are recruited and activated during reperfusion and mediate subsequent neutrophil-induced lung ischemia–reperfusion injury.

Methods: An in vivo mouse model of lung ischemia–reperfusion injury was used. C57BL/6 mice were assigned to either the sham group (left thoracotomy) or 7 study groups that underwent 1-hour left hilar occlusion followed by 1 to 24 hours of reperfusion. After in vivo reperfusion, the lungs were perfused ex vivo with buffer whereby pulmonary function was assessed. Lung vascular permeability, edema, neutrophil accumulation, and cytokine/chemokine production (tumor necrosis factor {alpha}, interleukin 17, CCL3, and CXCL1) were assessed based on Evans blue dye leak, wet/dry weight ratio, myeloperoxidase level, and enzyme-linked immunosorbent assay, respectively.

Results: A preliminary study showed that 2 hours of reperfusion resulted in greater pulmonary dysfunction than 1 or 24 hours of reperfusion. The 2-hour reperfusion period was thus used for the remaining experiments. Comparable and significant protection from ischemia–reperfusion injury–induced lung dysfunction and injury occurred after antibody depletion of neutrophils or CD4+ T cells but not CD8+ T cells (P < .05 vs immunoglobulin G control). Lung ischemia–reperfusion injury was proportional to the infiltration of neutrophils but not T cells. Moreover, pulmonary neutrophil infiltration and the production of CXCL1 (KC) were significantly diminished by CD4+ T-cell depletion but not vice versa.

Conclusions: Both CD4+ T lymphocytes and neutrophils accumulate during reperfusion and contribute sequentially to lung ischemia–reperfusion injury. The data suggest that neutrophils mediate ischemia–reperfusion injury; however, CD4+ T cells play a critical role in stimulating chemokine production and neutrophil chemotaxis during ischemia–reperfusion injury.



Abbreviations and Acronyms BAL = bronchoalveolar lavage; IFN-{gamma} = interferon {gamma}; IgG = immunoglobulin G; IL = interleukin; IRI = ischemia–reperfusion injury; LC = lung compliance; mAb = monoclonal antibody; MPO = myeloperoxidase; TNF-{alpha} = tumor necrosis factor {alpha}





This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. K. Sharma, V. E. Laubach, S. I. Ramos, Y. Zhao, G. Stukenborg, J. Linden, I. L. Kron, and Z. Yang
Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury
J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 474 - 482.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.